Key facts
- Notable investors include Shandong Finance Group, Yeda Economic Development Group.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Hengyu Biopharmaceutical
- ·The full record, as it builds
Funding rounds
No funding rounds for Hengyu Biopharmaceutical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Hengyu Biopharmaceutical
Developer of bioactive compounds intended for dermatological and cosmetic applications. The company offers proprietary extraction and purification technologies, quality-controlled production processes, and scalable manufacturing infrastructure, enabling the skincare and medical aesthetics market to access high-purity ingredients that support tissue regeneration, skin repair, and anti-aging treatments.
- Sector
- Healthcare
- HQ
- Hengyu, China
- Founded
- 2020
- Website
- en.hypdrn.com/
- Ownership
- Privately Held (backing)
Hengyu Biopharmaceutical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Hengyu Biopharmaceutical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Hengyu Biopharmaceutical in its N-PORT filings yet. We sweep new filings monthly.